Vaccine safety

Pediatric Infectious Disease Journal

Volumn 27, Issue 9, 2008, Pages 827-830

  Fisher, Margaret C ^a,b  

^a MONMOUTH MEDICAL CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Immunizations; Safety; Vaccines

Indexed keywords

CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; THIOMERSAL; VACCINE;

ADVISORY COMMITTEE; ASEPTIC MENINGITIS; DRUG SAFETY; ENTERITIS; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; HEALTH CARE DISPARITY; HERD IMMUNITY; HUMAN; LICENSING; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SEIZURE; UNITED STATES; VACCINATION REACTION; DRUG SURVEILLANCE PROGRAM;

ADVERSE DRUG REACTION REPORTING SYSTEMS; HUMANS; VACCINES;

EID: 53049097502     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181886129     Document Type: Article

References (21)

1. Roush SW, et al. Historical comparisons of morbidity and mortality for vaccine-prevent- able diseases in the United States. JAMA.2007;298:2155- 2163.
2. Luman ET, et al. Uptake of varicella vaccina- tion...: a success story in eliminating racial and ethnic disparities. Pediatrics. 2006;117: 999-1008.
3. Flannery B, et al. Impact of childhood vacci- nation on racial disparities.... JAMA. 2004; 291:2197-2203.
4. Lexau CA, et al. Changing epidemiology of invasive pneumococcal disease among older adults. JAMA 2005;294:2043-2051.
5. Orenstein WA, et al. The immunization sys- tem in the United States: the role of school immunization laws. Vaccine. 1999;17:S19- S24.
6. Redd SB, et al. Measles-United States, Janu- ary 1-April 25, 2008. MMWR. 2008;57: 494-498.
7. Parikh RK. Fighting for the reputation of vaccines: lessons from American politics. Pe- diatrics. 2008;121:621-622.
8. Food and Drug Administration. Content and format of INDs for Phase 1 studies of drugs, including well-characterized, therapeutic, bio- technology-derived products. Available at: www.fda.gov/cder/guidance/clin2.pdf- 02-16-1998. Accessed July 27, 2008.
9. Food and Drug Administration. Guidance for industry. CGMP for phase 1 investiga- tional drugs. Available at: http://www. fda.gov/cber/gdlns/indcgmp. pdf. Accessed July 27, 2008.
10. Centers for Disease Control and Prevention. Advisory Committee on Immunization Prac- tices (ACIP). Available at: http://www.cdc. gov/vaccines/recs/acip/default.htm. Accessed July 27, 2008.
11. Centers for Disease Control and Prevention. http://www.cdc.gov/ vaccinesafety/about-iso. htm. Accessed July 27, 2008.
12. Committee on the Review of the National Immunization Program's Research Proce- dures and Data Sharing Program, Board on Population Health and Public Health Prac- tice, Institute of Medicine. Vaccine Safety Research, Data Access, and Public Trust. The National Academies Press; 2005: 1-152.
13. Health Resources and Services Administra- tion. National Vaccine Injury Compensa- ion Program. Available at: www.hrsa.gov/ vaccinecompensation/table. htm. Accessed July 27, 2008.
14. Varricchio F, et al. Understanding vaccine safety information from.... Pediatr Infect Dis J. 2004;23:287-294.
15. Centers for Disease Control and Prevention. http://www.cdc.gov/ vaccinesafety/vsd/vsd- publications.htm. Accessed July 27, 2008.
16. Centers for Disease Control and Prevention. http:// www.cdc.gov/ vaccinesafety/cisa/. Accessed July 27, 2008.
17. The Brighton Collaboration. http://www. brightoncollaboration.org/ internet/en/ index.html. Accessed July 27, 2008.
18. Cooper LZ, et al. Protecting public trust in immunization. Pediatrics. 2008;122:149-153.
19. Offit PA, et al. Addressing parents' concerns: do multiple vaccines overwhelm. Pediatrics 2002;109:124-129.
20. Offit PA, et al. Addressing parents' concerns: do vaccines cause allergic. Pediatrics 2003; 111:653-659.
21. Offit PA, et al. Addressing parents' concerns: do vaccines contain harmful. Pediatrics 2003; 112:1394-1401.